This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
United Therapeutics Corporation
Drug Names(s): UT-231B
Description: UT-231B is a small molecule glycobiology antiviral agent.
Deal Structure: In March 2000, Unither entered into a license agreement with Synergy Pharmaceuticals, a subsidiary of Callisto Pharmaceuticals, to obtain from Synergy the exclusive worldwide rights to certain patents relating to novel antiviral compounds. UT-231B is one of these agents.
Partners: Synergy Pharmaceuticals, Inc.
Pink Sheet FDA Recalls For Aug. 12-19
Pink Sheet Weekly Trademark Review July 21, 2015
Pink Sheet Weekly Trademark Review Aug. 19, 2014
Additional information available to subscribers only: